News


Sygnature Discovery at BioJapan 2017 – Participating in UK Department of International Trade Mission

11th October 2017 – Yokohama, Japan – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, is participating in BioJapan 2017 from 11th – 13th October 2017 in Yokohama.  Sygnature is part of a UK Department of International Trade (UK DIT) Mission and is located on the UK Pavilion (Booth No. […]

Phoenix Equity Partners announces investment in Sygnature Discovery

9th October 2017 – London and Nottingham, UK – Phoenix Equity Partners (“Phoenix”), a leading UK middle-market private equity firm, today announces an investment in Sygnature Discovery Limited (“Sygnature” or “the Company”) alongside the current management team, led by Founder and CEO Dr Simon Hirst.  The deal will provide Sygnature with additional investment to support […]

Sygnature Discovery wins Best Contract Research Organisation Award at OBN Awards 2017

6th October 2017, Nottingham, UK – Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, has been named as the winner of the Best Contract Research Organisation award at the OBN Awards 2017. The OBN Awards 2017, now in their 9th year, celebrate innovation and outstanding achievement across the UK […]


View All News
Conferences

Meet Sygnature at the following Conferences throughout 2015:



Biotech Showcase/JP Morgan

9-11th January 2017
San Francisco USA


RSC OrgSyn 50

27-28 February 2017
Manchester UK


Proventa Medicinal Chemistry Strategy

14th March 2017
London



View All Conferences
Media

Sygnature Discovery



View All Media
Publications

KINASE INHIBITORS, FRICKEL, Fritz-Frieder

KINASE INHIBITORS, FRICKEL, Fritz-Frieder; FYFE, Matthew, Colin, Thor; MEGHANI, Premji; THOM, Stephen, Malcolm; (RespiVert Ltd. and TopiVert Ltd.), WO 2014076484 (2014).


PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne

PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS, DUFFY, Lorna Anne; KING-UNDERWOOD, John; LONGSHAW, Alistair Ian; MURRAY, Peter John; ONIONS, Stuart Thomas; TADDEI, David Michael Adrien; WILLIAMS, Jonathan Gareth; ITO, Kazuhiro; CHARRON, Catherine Elisabeth; (GB) (RespiVert Ltd. and TopiVert Ltd.), WO 2014033448 (2014).


KINASE INHIBITORS, FYFE, Matthew Colin Thor

KINASE INHIBITORS, FYFE, Matthew Colin Thor; MEGHANI, Premji; STENT, Matthew Alexander Henry; THOM, Stephen Malcolm; WALSHE, Claire Anne; (RespiVert Ltd. and TopiVert Ltd.), WO 2014033447 (2014).



View All Publications
Search


Get in Touch


Vacancies
  • Posted: May 3, 2017
    Senior Scientists in DMPK

  • Posted: March 3, 2017
    Analytical Chemist


  • See more
    Latest news
  • Sygnature Discovery at BioJapan 2017 – Participating in UK Department of International Trade Mission
  • Copyright © 2017 Sygnature Discovery

    Website built by AtomicMedia - Design by Freestyle.